Bioceres Crop Solutions Corp(BIOX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 16 at 4:10 PM ET (Korea 9/17 05:10)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.76 | Insider Own | 18.15% | Shs Outstand | 63.2M | Perf Week | -9.47% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 51.8M | Perf Month | -11.69% |
| Enterprise Value | 0.27B | PEG | - | EPS next Q | - | Inst Own | 23.29% | Short Float | 0.63% | Perf Quarter | -5.48% |
| Income | -0.05B | P/S | 0.1 | EPS this Y | - | Inst Trans | -1.54% | Short Ratio | 1.15 | Perf Half Y | -6.76% |
| Sales | 0.25B | P/B | 0.37 | EPS next 5Y | - | ROA | -8.17% | Short Interest | 0.33M | Perf YTD | -70.53% |
| Book/sh | 1.04 | P/C | 2 | EPS past 3/5Y | - -33.3% | ROE | -34.19% | 52W High | -82.37% ($2.19) | Perf Year | -79.79% |
| Cash/sh | 0.19 | P/FCF | 0.36 | Sales past 3/5Y | -17.24% 2.84% | ROIC | -44.63% | 52W Low | 28.11% ($0.30) | Perf 3Y | -96.56% |
| Dividend Est. | - | EV/EBITDA | 19.87 | EPS Y/Y TTM | 14.85% | Gross Margin | 38.1% | Volatility(W/M) | 8.12% 11.34% | Perf 5Y | -97% |
| Dividend TTM | - | EV/Sales | 1.11 | Sales Y/Y TTM | -26.1% | Oper. Margin | -1.26% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.63 | EPS Q/Q | 51.07% | Profit Margin | -19.59% | RSI (14) | 43.15 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.81 | Sales Q/Q | -23.35% | SMA20 | -8.82% ($0.43) | Beta | 0.45 | Target Price | $2 |
| Payout | - | Debt/Eq | 6.06 | Earnings | 2026/9/14 | SMA50 | 0.23% ($0.39) | Rel Volume | 0.45 | Prev Close | $0.4 |
| Employees | 751 | LT Debt/Eq | 1.76 | EPS/Sales Surpr. | - | SMA200 | -40.71% ($0.66) | Avg Volume(3M) | 0.29M | Price | $0.39 |
| IPO | 2018/3/22 | Option/Short | Yes/Yes | Trades | 534 | Volume | 127,231 | Change | -4.57% |
Company
BIOX is a Basic Materials sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🌾 Bioceres Crop Solutions () is an Argentina-based seed and biological agricultural inputs company that offers drought-tolerant GM soybeans called 'HB4', as well as inoculants, fertilizers, and biocontrol products. Recently, the company has been pushing to transition to a more capital-efficient business model.
Over the past 1 year, on the lower side
82% below its 1-year high.
BIOX has weak earning power
Review management risk carefully before investing
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -96.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 23.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
QQQS 0.00%
KROP 0.00%
ARGT 0.00%It ranks #4 in the industry
Based on market cap of $24M.
BIOX $24M PER -
CTVA $54B PER 53.6
NTR $37B PER 15.7
CF $20B PER 9.8
FAQ
What kind of company is BIOX?
BIOX belongs to the Basic Materials sector and operates in the Agricultural Inputs industry.
What is the market cap of BIOX?
The market cap of BIOX is approximately $24M, ranking 5,211 within its sector.
What is the 52-week high and low for BIOX?
BIOX has recorded a 52-week high of $2.19 and a low of $0.30.
